• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Development and application of novel performance validity metrics for computerized neurocognitive batteries.新型计算机神经认知成套测验的性能效度指标的开发与应用。
J Int Neuropsychol Soc. 2023 Oct;29(8):789-797. doi: 10.1017/S1355617722000893. Epub 2022 Dec 12.
2
Education support services for improving school engagement and academic performance of children and adolescents with a chronic health condition.改善患有慢性病的儿童和青少年的学校参与度和学业成绩的教育支持服务。
Cochrane Database Syst Rev. 2023 Feb 8;2(2):CD011538. doi: 10.1002/14651858.CD011538.pub2.
3
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
4
Short-Term Memory Impairment短期记忆障碍
5
Factors that influence parents' and informal caregivers' views and practices regarding routine childhood vaccination: a qualitative evidence synthesis.影响父母和非正式照顾者对常规儿童疫苗接种看法和做法的因素:定性证据综合分析。
Cochrane Database Syst Rev. 2021 Oct 27;10(10):CD013265. doi: 10.1002/14651858.CD013265.pub2.
6
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
7
A New Measure of Quantified Social Health Is Associated With Levels of Discomfort, Capability, and Mental and General Health Among Patients Seeking Musculoskeletal Specialty Care.一种新的量化社会健康指标与寻求肌肉骨骼专科护理的患者的不适程度、能力以及心理和总体健康水平相关。
Clin Orthop Relat Res. 2025 Apr 1;483(4):647-663. doi: 10.1097/CORR.0000000000003394. Epub 2025 Feb 5.
8
Measures implemented in the school setting to contain the COVID-19 pandemic.学校为控制 COVID-19 疫情而采取的措施。
Cochrane Database Syst Rev. 2022 Jan 17;1(1):CD015029. doi: 10.1002/14651858.CD015029.
9
Incentives for preventing smoking in children and adolescents.预防儿童和青少年吸烟的激励措施。
Cochrane Database Syst Rev. 2017 Jun 6;6(6):CD008645. doi: 10.1002/14651858.CD008645.pub3.
10
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.

引用本文的文献

1
Performance validity testing: the need for digital technology and where to go from here.性能效度测试:数字技术的需求及未来发展方向
Front Psychol. 2024 Aug 13;15:1452462. doi: 10.3389/fpsyg.2024.1452462. eCollection 2024.
2
Measuring Cognitive Impairments Associated With Schizophrenia in Clinical Practice: Overview of Current Challenges and Future Opportunities.在临床实践中测量与精神分裂症相关的认知障碍:当前挑战与未来机遇概述
Schizophr Bull. 2025 Mar 14;51(2):401-421. doi: 10.1093/schbul/sbae051.
3
Validation of the cognitive section of the Penn computerized adaptive test for neurocognitive and clinical psychopathology assessment (CAT-CCNB).验证宾夕法尼亚计算机化自适应测试在神经认知和临床精神病理学评估中的认知部分(CAT-CCNB)。
Brain Cogn. 2024 Feb;174:106117. doi: 10.1016/j.bandc.2023.106117. Epub 2023 Dec 20.
4
Construction of a computerized adaptive test (CAT-CCNB) for efficient neurocognitive and clinical psychopathology assessment.构建用于高效神经认知和临床精神病理学评估的计算机化自适应测试(CAT-CCNB)。
J Neurosci Methods. 2023 Feb 15;386:109795. doi: 10.1016/j.jneumeth.2023.109795. Epub 2023 Jan 16.
5
Test-Retest Reliability of a Computerized Neurocognitive Battery in School-Age Children with HIV in Botswana.博茨瓦纳感染 HIV 学龄儿童计算机神经认知成套测验的重测信度。
Arch Clin Neuropsychol. 2023 Jan 21;38(1):131-138. doi: 10.1093/arclin/acac066.

本文引用的文献

1
Neurocognitive predictors of treatment outcomes in psychotherapy for comorbid PTSD and substance use disorders.共病 PTSD 和物质使用障碍的心理治疗中神经认知预测因子与治疗结果的关系。
J Consult Clin Psychol. 2021 Nov;89(11):937-946. doi: 10.1037/ccp0000693.
2
Adaptation and validation of a computerized neurocognitive battery in the Xhosa of South Africa.南非科萨语版计算机神经认知成套测验的修订与验证。
Neuropsychology. 2021 Sep;35(6):581-594. doi: 10.1037/neu0000742. Epub 2021 Jul 5.
3
Development of embedded performance validity indicators in the NIH Toolbox Cognitive Battery.在 NIH 工具包认知电池中开发嵌入式绩效有效性指标。
Psychol Assess. 2021 Jan;33(1):90-96. doi: 10.1037/pas0000958. Epub 2020 Oct 29.
4
Distinct and shared contributions of diagnosis and symptom domains to cognitive performance in severe mental illness in the Paisa population: a case-control study.帕萨人群重度精神疾病中诊断和症状领域对认知表现的独特和共同贡献:病例对照研究。
Lancet Psychiatry. 2020 May;7(5):411-419. doi: 10.1016/S2215-0366(20)30098-5.
5
Base Rates of Invalid Test Performance Across Clinical Non-forensic Contexts and Settings.临床非法医情境和环境下无效测试表现的基本比率。
Arch Clin Neuropsychol. 2020 Aug 28;35(6):717-725. doi: 10.1093/arclin/acaa017.
6
Estimation of Response Styles Using the Multidimensional Nominal Response Model: A Tutorial and Comparison With Sum Scores.使用多维名义反应模型估计反应风格:教程及与总分的比较
Front Psychol. 2020 Feb 6;11:72. doi: 10.3389/fpsyg.2020.00072. eCollection 2020.
7
Genetics of schizophrenia in the South African Xhosa.南非科萨人的精神分裂症遗传学。
Science. 2020 Jan 31;367(6477):569-573. doi: 10.1126/science.aay8833.
8
Neurostructural Heterogeneity in Youths With Internalizing Symptoms.具有内化症状的青少年的神经结构异质性。
Biol Psychiatry. 2020 Mar 1;87(5):473-482. doi: 10.1016/j.biopsych.2019.09.005. Epub 2019 Sep 18.
9
Genome-wide Association of Endophenotypes for Schizophrenia From the Consortium on the Genetics of Schizophrenia (COGS) Study.全基因组关联研究精神分裂症内表型的精神分裂症遗传学联合会(COGS)研究。
JAMA Psychiatry. 2019 Dec 1;76(12):1274-1284. doi: 10.1001/jamapsychiatry.2019.2850.
10
If Invalid PVT Scores Are Obtained, Can Valid Neuropsychological Profiles Be Believed?如果获得了无效的 PVT 分数,是否可以相信有效的神经心理学特征?
Arch Clin Neuropsychol. 2019 Oct 24;34(7):1192-1202. doi: 10.1093/arclin/acz028.

新型计算机神经认知成套测验的性能效度指标的开发与应用。

Development and application of novel performance validity metrics for computerized neurocognitive batteries.

机构信息

Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

VISN4 Mental Illness Research, Education, and Clinical Center at the Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA, USA.

出版信息

J Int Neuropsychol Soc. 2023 Oct;29(8):789-797. doi: 10.1017/S1355617722000893. Epub 2022 Dec 12.

DOI:10.1017/S1355617722000893
PMID:36503573
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10258222/
Abstract

OBJECTIVES

Data from neurocognitive assessments may not be accurate in the context of factors impacting validity, such as disengagement, unmotivated responding, or intentional underperformance. Performance validity tests (PVTs) were developed to address these phenomena and assess underperformance on neurocognitive tests. However, PVTs can be burdensome, rely on cutoff scores that reduce information, do not examine potential variations in task engagement across a battery, and are typically not well-suited to acquisition of large cognitive datasets. Here we describe the development of novel performance validity measures that could address some of these limitations by leveraging psychometric concepts using data embedded within the Penn Computerized Neurocognitive Battery (PennCNB).

METHODS

We first developed these validity measures using simulations of invalid response patterns with parameters drawn from real data. Next, we examined their application in two large, independent samples: 1) children and adolescents from the Philadelphia Neurodevelopmental Cohort ( = 9498); and 2) adult servicemembers from the Marine Resiliency Study-II ( = 1444).

RESULTS

Our performance validity metrics detected patterns of invalid responding in simulated data, even at subtle levels. Furthermore, a combination of these metrics significantly predicted previously established validity rules for these tests in both developmental and adult datasets. Moreover, most clinical diagnostic groups did not show reduced validity estimates.

CONCLUSIONS

These results provide proof-of-concept evidence for multivariate, data-driven performance validity metrics. These metrics offer a novel method for determining the performance validity for individual neurocognitive tests that is scalable, applicable across different tests, less burdensome, and dimensional. However, more research is needed into their application.

摘要

目的

在影响效度的因素(如脱机、无动机反应或故意表现不佳)背景下,神经认知评估数据可能不准确。为了解决这些现象并评估神经认知测试中的表现不佳,开发了绩效效度测试(PVT)。然而,PVT 可能会带来负担,依赖于降低信息量的截断分数,不检查电池内任务参与的潜在变化,并且通常不适合获取大型认知数据集。在这里,我们描述了开发新的绩效效度测量方法的进展,这些方法可以通过利用心理计量学概念并利用 Penn 计算机化神经认知电池(PennCNB)中嵌入的数据来解决这些限制。

方法

我们首先使用从真实数据中提取参数的无效反应模式模拟来开发这些有效性测量方法。接下来,我们在两个独立的大型样本中检查了它们的应用:1)费城神经发育队列中的儿童和青少年(n = 9498);2)海洋适应研究 II 中的成年军人(n = 1444)。

结果

我们的绩效效度指标在模拟数据中检测到了无效反应模式,即使在细微水平也是如此。此外,这些指标的组合在发育和成人数据集中都显著预测了先前为这些测试建立的有效性规则。此外,大多数临床诊断组并未显示出较低的效度估计值。

结论

这些结果为基于多元、数据驱动的绩效效度指标提供了概念验证证据。这些指标为确定个别神经认知测试的绩效效度提供了一种新颖的方法,该方法具有可扩展性、适用于不同测试、负担更小且具有维度性。然而,还需要更多的研究来应用这些指标。